Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
100.24
Dollar change
-1.54
Percentage change
-1.51
%
Index- P/E- EPS (ttm)-7.72 Insider Own0.79% Shs Outstand159.00M Perf Week-9.74%
Market Cap15.88B Forward P/E19.44 EPS next Y5.16 Insider Trans0.00% Shs Float157.15M Perf Month-26.40%
Income-1222.00M PEG- EPS next Q0.96 Inst Own98.56% Short Float4.14% Perf Quarter-32.10%
Sales4.37B P/S3.63 EPS this Y8.56% Inst Trans2.84% Short Ratio2.84 Perf Half Y-18.02%
Book/sh14.92 P/B6.72 EPS next Y14.17% ROA-14.89% Short Interest6.51M Perf Year-22.88%
Cash/sh7.70 P/C13.01 EPS next 5Y11.98% ROE-30.11% 52W Range97.27 - 156.66 Perf YTD-24.99%
Dividend Est.- P/FCF22.39 EPS past 5Y- ROI-27.67% 52W High-36.01% Beta1.13
Dividend TTM- Quick Ratio1.42 Sales past 5Y5.55% Gross Margin65.44% 52W Low3.06% ATR (14)5.70
Dividend Ex-Date- Current Ratio1.78 EPS Y/Y TTM-4.69% Oper. Margin26.88% RSI (14)21.95 Volatility4.16% 3.97%
Employees10370 Debt/Eq1.10 Sales Y/Y TTM-2.93% Profit Margin-27.95% Recom2.33 Target Price145.83
Option/ShortYes / Yes LT Debt/Eq0.86 EPS Q/Q205.59% Payout- Rel Volume1.36 Prev Close101.78
Sales Surprise1.68% EPS Surprise4.08% Sales Q/Q-1.60% EarningsFeb 06 AMC Avg Volume2.29M Price100.24
SMA20-19.28% SMA50-24.70% SMA200-21.01% Trades Volume3,109,631 Change-1.51%
Date Action Analyst Rating Change Price Target Change
Feb-10-25Downgrade Barclays Equal Weight → Underweight $130 → $100
Feb-07-25Downgrade TD Cowen Buy → Hold $177 → $140
Dec-11-24Downgrade Citigroup Buy → Neutral $190 → $165
Nov-12-24Resumed Morgan Stanley Equal-Weight $156
Oct-17-24Upgrade HSBC Securities Hold → Buy $180
Aug-28-24Upgrade Argus Hold → Buy
Aug-16-24Upgrade Daiwa Securities Neutral → Buy $120 → $154
Aug-14-24Upgrade TD Cowen Hold → Buy $126 → $144
Aug-14-24Upgrade Barclays Underweight → Equal Weight $125
Jul-10-24Upgrade Citigroup Neutral → Buy $140
Feb-14-25 12:00AM
Feb-13-25 01:57PM
01:43PM
Feb-12-25 05:57PM
09:45AM
08:03AM Loading…
08:03AM
Feb-11-25 09:40AM
09:32AM
08:06AM
Feb-10-25 05:12PM
02:56PM
11:11AM
09:15AM
08:23AM
Feb-07-25 07:19PM
03:03PM Loading…
03:03PM
02:57PM
11:37AM
07:47AM
02:24AM
Feb-06-25 07:54PM
07:00PM
06:05PM
05:09PM
04:48PM
04:42PM
04:05PM
Feb-05-25 08:13AM
07:22AM
06:10AM
04:30AM Loading…
04:30AM
Feb-04-25 09:32PM
06:38PM
12:23PM
10:52AM
10:26AM
09:35AM
09:29AM
02:08AM
12:57AM
Feb-03-25 09:16AM
Jan-30-25 10:01AM
Jan-29-25 09:48PM
Jan-28-25 10:30AM
Jan-23-25 09:50AM
Jan-22-25 12:21PM
10:30AM
Jan-16-25 12:10PM
10:00AM
Jan-15-25 12:07PM
Jan-14-25 11:49AM
09:22AM
09:00AM
Jan-13-25 02:12PM
12:25PM
11:29AM
10:27AM
09:01AM
09:00AM
07:02AM
06:07AM
03:01AM
Jan-09-25 04:22PM
Jan-07-25 09:15AM
Jan-03-25 06:46AM
06:45AM
Dec-23-24 07:30AM
Dec-20-24 07:44PM
12:56PM
07:44AM
Dec-19-24 02:11PM
Dec-18-24 10:15AM
Dec-17-24 09:13AM
Dec-16-24 01:43PM
10:30AM
10:28AM
09:25AM
08:25AM
Dec-13-24 08:20PM
08:00PM
08:17AM
Dec-12-24 10:30AM
Dec-10-24 03:00PM
Dec-04-24 04:07PM
11:30AM
03:30AM
Nov-25-24 05:41PM
Nov-22-24 03:40PM
Nov-20-24 04:30PM
03:29PM
10:43AM
07:57AM
Nov-19-24 09:15AM
Nov-18-24 09:16AM
Nov-11-24 11:59PM
09:50AM
Nov-08-24 09:40AM
Nov-07-24 09:15AM
12:04AM
Nov-06-24 04:05PM
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHARLES E. DADSWELL TRUST U/A/OfficerOct 14 '24Proposed Sale145.544,948720,132Oct 15 08:03 AM
CHARLES E. DADSWELL TRUST U/A/OfficerAug 15 '24Proposed Sale122.283,956483,740Aug 15 04:31 PM
Thaysen JacobChief Executive OfficerFeb 22 '24Buy135.297,330991,67214,861Feb 26 08:57 AM